Content
01/31/2019
Tempe, AZ USA
GT Medical Technologies
completed $10 million Series A Round funding. Investors include
Medical Technology Venture Partners (lead), BlueStone Venture Partners.
About
GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 1000+ patients with brain tumors.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
